ADXS Insider Holders & Insider Ownership - Ayala Pharmaceuticals Inc.

List of insiders holdings for Ayala Pharmaceuticals Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner	2024-03-06 07:13:01	0 51,900,000	51,900,000	Form 4
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 10% Owner	2005-01-13 12:07:00	6,339,282 0	6,339,282	Form 13D
LOW NATHAN A 10% Owner	2004-12-10 19:36:22	1,850,622 4,216,027	6,066,649	Form 4
FLAMM SCOTT Director	2005-12-13 11:09:06	374,295 2,630,235	3,004,530	Form 3/A
ROTHMAN JOHN F Exec VP of Science and Ops	2011-11-10 20:45:27	3,000,000 0	3,000,000	Form 4
ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner	2019-02-13 13:35:49	2,500,000 0	2,500,000	Form 13G
DERBIN JON TODD CEO and President	2004-11-16 17:31:43	1,837,348 0	1,837,348	Form 3
COBB FREDRICK D Vice President Finance	2009-08-07 13:32:40	1,450,000 0	1,450,000	Form 4
Cabilly Yuval Director	2023-11-08 16:01:18	0 1,298,639	1,298,639	Form 3
O'Connor Daniel Chief Executive Officer	2017-07-03 16:30:20	618,352 0	618,352	Form 4
aMoon Growth Fund Limited Partnership 10% Owner	2023-10-23 06:43:18	560,602 0	560,602	Form 4
aMoon Growth Fund Limited Partnership Schindel Yair Chaim 10% Owner	2024-02-12 08:27:51	560,602 0	560,602	Form 13G
PETIT ROBERT Chief Scientific Officer	2018-11-07 17:00:24	381,206 0	381,206	Form 4
Bonstein Sara Chief Financial Officer	2018-04-03 16:30:15	226,670 0	226,670	Form 4
MOORE THOMAS A Former Director Director	2014-07-18 17:08:14	176,462 0	176,462	Form 4
Mauro David J Chief Medical Officer	2016-01-04 16:30:13	166,271 0	166,271	Form 4
WADE MARTIN R III Director	2006-06-22 16:39:18	150,000 0	150,000	Form 3
Rosenblum Mark J Chief Financial Officer	2014-02-04 19:28:06	113,774 0	113,774	Form 4
Mayes Gregory T. Director	2017-01-03 17:28:30	103,841 0	103,841	Form 4
ROTH STEPHEN ALLEN Director	2004-11-16 17:40:49	82,763 0	82,763	Form 3
LOMBARDO ANTHONY A Interim CEO	2018-04-18 16:30:40	81,852 0	81,852	Form 4
FRENCH CHRISTY LEE VP-Regulatory, Medical Affairs	2015-01-02 16:34:46	71,938 0	71,938	Form 4
Gutierrez Andres Executive Vice President & CMO	2020-05-05 16:00:24	50,000 0	50,000	Form 4
Berlin Kenneth A President and CEO	2020-05-05 16:00:36	50,000 0	50,000	Form 4
Henderson Molly Executive Vice President & CFO	2020-05-05 16:00:45	50,000 0	50,000	Form 4
Gitelman Igor Chief Accounting Officer	2021-02-16 16:30:31	50,000 0	50,000	Form 3
Ridge Thomas J Director	2017-11-06 18:00:27	25,000 0	25,000	Form 4
MCKEARN THOMAS J Director	2017-11-06 18:00:28	25,000 0	25,000	Form 4
BERMAN RICHARD J Director	2020-05-05 16:00:27	13,000 0	13,000	Form 4
Khleif Samir N Director	2020-05-05 16:00:42	13,000 0	13,000	Form 4
APPEL RONI Director	2020-05-05 16:00:39	13,000 0	13,000	Form 4
PATTON JAMES P Director	2020-05-05 16:00:33	13,000 0	13,000	Form 4
GOLDBERG MURRAY A Director	2023-01-23 18:18:59	7,963 0	7,963	Form 4
Spiegel Robert J. Director	2023-01-23 18:16:12	7,963 0	7,963	Form 4
SIDRANSKY DAVID Director	2023-01-23 18:19:33	5,199 46	5,245	Form 4
Bisker-Leib Vered Director	2023-01-23 18:17:33	3,981 0	3,981	Form 4
Martell Bridget A Director	2023-11-03 11:43:16	0 0	0	Form 3/A
Orbach Pini Director	2023-11-03 11:45:26	0 0	0	Form 3/A
Golan Roy Chief Financial Officer	2023-11-03 11:46:10	0 0	0	Form 3/A

Insider Holders & Insider Ownership - Ayala Pharmaceuticals Inc. (ADXS)